Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane F Apperley

Showing results (51-60 of 195) with videos related to

Pageof 20
Sort By:
European Journal of Haematology|November 8, 2018
Back to the future: Treatment-free remission and pregnancy in chronic myeloid leukemiaElisabetta Abruzzese, Paolo de Fabritiis, Malgorzata M Trawinska, et al.
Haematologica|September 10, 2002
The use of imatinib (STI571) in chronic myelod leukemia: some practical considerationsDavid Marin, Sarah Marktel, Marco Bua, et al.
British Journal of Haematology|April 13, 2007
Dual inhibition of ras and bcr-abl signalling pathways in chronic myeloid leukaemia: a phase I/II study in patients in complete haematological remissionJiri Pavlu, Catharina Andreasson, Charles Chuah, et al.
Blood|December 18, 2012
Significant weight gain in patients with chronic myeloid leukemia after imatinib therapyElvis Aduwa, Richard Szydlo, David Marin, et al.
Blood|May 14, 2010
In search of the original leukemic clone in chronic myeloid leukemia patients in complete molecular remission after stem cell transplantation or imatinibManuel Sobrinho-Simões, Vicki Wilczek, Joannah Score, et al.
American Journal of Hematology|July 29, 2016
Cognitive dysfunction after withdrawal of tyrosine kinase inhibitor therapy in chronic myeloid leukaemiaSimone Claudiani, Jane F Apperley, Simona Deplano, et al.
Leukemia Research|April 17, 2007
Incidence of hyperthyroidism after unrelated donor allogeneic stem cell transplantationJolanta B Perz, David Marin, Richard M Szydlo, et al.
British Journal of Haematology|July 25, 2003
Clinical heterogeneity in chronic myeloid leukaemia reflecting biological diversity in normal personsMyrtle Y Gordon, Stephen B Marley, Jane F Apperley, et al.
Blood|June 21, 2008
Association between BMI-1 expression, acute graft-versus-host disease, and outcome following allogeneic stem cell transplantation from HLA-identical siblings in chronic myeloid leukemiaMohamad Mohty, Richard M Szydlo, Agnes S M Yong, et al.
Cancer Genetics and Cytogenetics|April 15, 2008
Deletions adjacent to BCR and ABL1 breakpoints occur in a substantial minority of chronic myeloid leukemia patients with masked Philadelphia rearrangementsValeria A S De Melo, Dragana Milojkovic, David Marin, et al.
Pageof 20

Showing results (51-60 of 195) with videos related to

Sort By:
Pageof 20
European Journal of Haematology|November 8, 2018
Back to the future: Treatment-free remission and pregnancy in chronic myeloid leukemiaElisabetta Abruzzese, Paolo de Fabritiis, Malgorzata M Trawinska, et al.
Haematologica|September 10, 2002
The use of imatinib (STI571) in chronic myelod leukemia: some practical considerationsDavid Marin, Sarah Marktel, Marco Bua, et al.
British Journal of Haematology|April 13, 2007
Dual inhibition of ras and bcr-abl signalling pathways in chronic myeloid leukaemia: a phase I/II study in patients in complete haematological remissionJiri Pavlu, Catharina Andreasson, Charles Chuah, et al.
Blood|December 18, 2012
Significant weight gain in patients with chronic myeloid leukemia after imatinib therapyElvis Aduwa, Richard Szydlo, David Marin, et al.
Blood|May 14, 2010
In search of the original leukemic clone in chronic myeloid leukemia patients in complete molecular remission after stem cell transplantation or imatinibManuel Sobrinho-Simões, Vicki Wilczek, Joannah Score, et al.
American Journal of Hematology|July 29, 2016
Cognitive dysfunction after withdrawal of tyrosine kinase inhibitor therapy in chronic myeloid leukaemiaSimone Claudiani, Jane F Apperley, Simona Deplano, et al.
Leukemia Research|April 17, 2007
Incidence of hyperthyroidism after unrelated donor allogeneic stem cell transplantationJolanta B Perz, David Marin, Richard M Szydlo, et al.
British Journal of Haematology|July 25, 2003
Clinical heterogeneity in chronic myeloid leukaemia reflecting biological diversity in normal personsMyrtle Y Gordon, Stephen B Marley, Jane F Apperley, et al.
Blood|June 21, 2008
Association between BMI-1 expression, acute graft-versus-host disease, and outcome following allogeneic stem cell transplantation from HLA-identical siblings in chronic myeloid leukemiaMohamad Mohty, Richard M Szydlo, Agnes S M Yong, et al.
Cancer Genetics and Cytogenetics|April 15, 2008
Deletions adjacent to BCR and ABL1 breakpoints occur in a substantial minority of chronic myeloid leukemia patients with masked Philadelphia rearrangementsValeria A S De Melo, Dragana Milojkovic, David Marin, et al.
Pageof 20